Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS
· Delayed Price · Currency is USD
0.3890
-0.0111 (-2.77%)
Jul 3, 2025, 4:00 PM EDT
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $483.33 thousand as of July 3, 2025. Its market cap has decreased by -76.78% in one year.
Market Cap
483.33K
Enterprise Value
-1.03M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.39
Market Cap Chart
Since February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from 32.29M to 483.33K, a decrease of -98.50%. That is a compound annual growth rate of -61.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 483.33K | -84.27% |
| Dec 31, 2024 | 3.07M | -18.06% |
| Dec 29, 2023 | 3.75M | -48.56% |
| Dec 30, 2022 | 7.29M | -81.86% |
| Dec 31, 2021 | 40.18M | 24.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.63B |
| Veradigm | 823.67M |
| Nika Pharmaceuticals | 708.22M |
| Elite Pharmaceuticals | 640.84M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 541.69M |
| American Oncology Network | 443.39M |
| Northwest Biotherapeutics | 363.62M |